Shengyou Ge

No. 16 Jiangsu Road
Qingdao, 266003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Retraction Note: Silencing POLE2 promotes apoptosis and inhibits proliferation of oral squamous cell carcinomas by inhibiting PI3K/AKT signaling pathway.

Retraction Note: Silencing POLE2 promotes apoptosis and inhibits proliferation of oral squamous cell carcinomas by inhibiting PI3K/AKT signaling pathway.

Journal: Medical oncology (Northwood, London, England)

Published: April 26, 2024

Expression and clinical significance of U2AF homology motif kinase 1 in oral squamous cell carcinoma.

Expression and clinical significance of U2AF homology motif kinase 1 in oral squamous cell carcinoma.

Journal: Oral surgery, oral medicine, oral pathology and oral radiology

Published: February 27, 2024

Prognostic significance of serum Chemerin and neutrophils levels in patients with oral squamous cell carcinoma.

Prognostic significance of serum Chemerin and neutrophils levels in patients with oral squamous cell carcinoma.

Journal: Heliyon

Published: January 27, 2024

The application of myofascial anterolateral thigh flap in reconstruction of oropharyngeal defect: a case report.

The application of myofascial anterolateral thigh flap in reconstruction of oropharyngeal defect: a case report.

Journal: Brazilian journal of otorhinolaryngology

Published: August 14, 2023

Silencing POLE2 promotes apoptosis and inhibits proliferation of oral squamous cell carcinomas by inhibiting PI3K/AKT signaling pathway.

Silencing POLE2 promotes apoptosis and inhibits proliferation of oral squamous cell carcinomas by inhibiting PI3K/AKT signaling pathway.

Journal: Medical oncology (Northwood, London, England)

Published: May 29, 2023

Neutrophils regulate tumor angiogenesis in oral squamous cell carcinoma and the role of Chemerin.

Neutrophils regulate tumor angiogenesis in oral squamous cell carcinoma and the role of Chemerin.

Journal: International immunopharmacology

Published: April 16, 2023

Nanosilica-Anchored Polycaprolactone/Chitosan Nanofibrous Bioscaffold to Boost Osteogenesis for Bone Tissue Engineering.

Nanosilica-Anchored Polycaprolactone/Chitosan Nanofibrous Bioscaffold to Boost Osteogenesis for Bone Tissue Engineering.

Journal: Molecules (Basel, Switzerland)

Published: November 13, 2022

Success in Emergency Treatment of Neonatal Giant Teratoma with Cleft Palate: A Case Report.

Success in Emergency Treatment of Neonatal Giant Teratoma with Cleft Palate: A Case Report.

Journal: The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association

Published: June 24, 2022

Efficacy and Safety of Pembrolizumab Monotherapy for Recurrent/Unresectable/Metastatic Oral Squamous Cell Carcinoma: A Single-Center Study in China.

Efficacy and Safety of Pembrolizumab Monotherapy for Recurrent/Unresectable/Metastatic Oral Squamous Cell Carcinoma: A Single-Center Study in China.

Journal: Journal of oncology

Published: June 13, 2022

Neutrophils Promote Tumor Progression in Oral Squamous Cell Carcinoma by Regulating EMT and JAK2/STAT3 Signaling Through Chemerin.

Neutrophils Promote Tumor Progression in Oral Squamous Cell Carcinoma by Regulating EMT and JAK2/STAT3 Signaling Through Chemerin.

Journal: Frontiers in oncology

Published: November 09, 2021

Assessment of the observation management of sialocele after partial superficial parotidectomy.

Assessment of the observation management of sialocele after partial superficial parotidectomy.

Journal: Oral diseases

Published: September 01, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026